News

Researchers at the University of Helsinki in collaboration with researchers from Åbo Akademi University (Finland) and Huazhong University of...

Broadening its oncolytic virus and tumour antigen-based immuno-oncology approach across enveloped viruses. Valo Therapeutics is a spin-out...

Prof. Hélder A. Santos from the University of Helsinki, Faculty of Pharmacy, was appointed the Chair of the Controlled Release Society (CRS)...

M. Med. Zehua Liu from Santos Lab, University of Helsinki has developed during his doctoral studies several porous silicon nanoparticle based...

Porous silicon and adenovirus-based biohybrid nanovaccines were developed in a study carried out at the University of Helsinki, providing new...

A recent study of enzyme inhibitors revealed potential new routes to anti-malarial drugs.

How can we trick the immune system into seeing tumours as infections? This is a question on the mind of Vincenzo Cerullo, a recently appointed...

The Professor of Biological Drug Development wants to understand how we can use our immune system to better fight cancer. Is our pre-existing...

ERC Proof of Concept grants can be used by ERC grantees to explore business opportunities. PeptiCHIP is a microfluidic chip-based device that...